Patent assignee · US · COMPANY

Sunovion Pharmaceuticals Inc.

🏢 View company profile →
131Patents
130Active
131Granted
58Portfolio score

Filing activity: Dec 21, 2006 → Mar 7, 2023 · 25 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8063032B2 Histamine H3 inverse agonists and antagonists and methods of use thereof Chemistry; Metallurgy 52 Active
US8053603B2 Tetralone-based monoamine reuptake inhibitors Chemistry; Metallurgy 24 Active
US8097625B2 Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression Human Necessities 21 Active
US10285953B2 Sublingual films Performing Operations; Transporting 17 Active
US8710245B2 Multicyclic compounds and methods of use thereof Chemistry; Metallurgy 16 Active
US10369134B2 Nonracemic mixtures and uses thereof Human Necessities 13 Active
US10377708B2 Crystal forms and production methods thereof Chemistry; Metallurgy 12 Active
US8969349B2 Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors Chemistry; Metallurgy 9 Active
US10577317B2 Crystal forms and production methods thereof Chemistry; Metallurgy 9 Active
US8772301B2 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof Chemistry; Metallurgy 9 Active
US10576058B2 Nonracemic mixtures and uses thereof Human Necessities 9 Active
US10660875B1 Nonracemic mixtures and uses thereof Human Necessities 9 Active
US8134029B2 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Chemistry; Metallurgy 7 Active
US10196403B2 Compounds and compositions and uses thereof Chemistry; Metallurgy 7 Active
US10874639B2 Nonracemic mixtures and uses thereof Human Necessities 7 Active
US10336732B2 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders Chemistry; Metallurgy 7 Active
US9351954B2 Multicyclic compounds and methods of use thereof Chemistry; Metallurgy 7 Active
US9249162B2 Substituted [1,2,4]triazolo[1,5-a]pyridines as PDE-10 inhibitors Chemistry; Metallurgy 7 Active
US10085968B2 Multicyclic compounds and methods of use thereof Chemistry; Metallurgy 7 Active
US9669019B2 Sublingual apomorphine Emerging Cross-Sectional Technologies 6 Active
US9669021B2 Sublingual apomorphine Emerging Cross-Sectional Technologies 6 Active
US8097760B2 Preparation of chiral amides and amines Chemistry; Metallurgy 5 Active
US11160758B2 Modified release formulations and uses thereof Human Necessities 5 Active
US9669020B2 Sublingual apomorphine Emerging Cross-Sectional Technologies 5 Active
US9669018B2 Sublingual apomorphine Emerging Cross-Sectional Technologies 5 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.